RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
Phase 2
Not yet recruiting
- Conditions
- Cognitive DeclineAlzheimer DiseaseMild Cognitive Impairment
- Interventions
- Drug: Resveratrol, Quercetin, and Curcumin (RQC)
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Zaparackas and Knepper LTD
- Target Recruit Count
- 200
- Registration Number
- NCT06470061
- Locations
- 🇺🇸
Zaparackas & Knepper Ltd., Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath